Hot penny stocks... don't get burned
   

NASDAQ Stock

Hansen Natural Cp

Hansen Natural Corporation was incorporated in Delaware on April 25, 1990. Its principal place of business is at 1010 Railroad Street, Corona, California 92882 and its telephone number is (951) 739-6200. When this report uses the words "Hansen", "HBC", "the Company", "we", "us", and "our", these words refer to Hansen Natural Corporation and our subsidiaries other than Monster ... more

Teva Pharm Ind, Inc Adr

Ligand Pharm

     We are an early-stage biotech company that focuses on discovering and developing new drugs that address critical unmet medical needs in the areas of thrombocytopenia, cancer, hepatitis C, hormone-related diseases, osteoporosis and inflammatory diseases. We strive to develop drugs that are more effective and/or safer than existing therapies, that are more ... more

Illumina, Inc

Biogen Idec, Inc

Ual Corp

Electronic Arts

  •  In-home video game players (such as the Sony PlayStation ®  2, Microsoft Xbox ® and Xbox 360 tm and Nintendo GameCube tm ) — we call these players “consoles”,     •  Personal computers ... more

Opsware, Inc

Vitesse Semiconductor

The fabrication of integrated circuits is a highly complex and technically demanding process. Defects in designs, problems associated with transitions to newer manufacturing processes and the inadvertent use of defective or contaminated materials can result in unacceptable manufacturing yields and performance. These problems are frequently difficult to detect in the early stages of the ... more

Gilead Science

Nutralogix Labs, Inc

Emdeon

United Svcs Glbl Inv, Inc Cl A

Encysive Pharm

     Encysive Pharmaceuticals Inc. is a global biopharmaceutical company that engages in the discovery, development and commercialization of novel, synthetic, small molecule compounds to address unmet medical needs. We focus our research and development programs predominantly on the treatment and prevention of interrelated diseases of the vascular endothelium and ... more

Medicines Co (the)

We exclusively licensed Angiomax from Biogen Idec, Inc. in 1997 and we have exclusive license rights to develop, market and sell Angiomax worldwide. We received our first marketing approval from the U.S. Food and Drug Administration, or the FDA, in December 2000 for Angiomax for use as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous ... more

previous  3  4  5  6  7  8  9  10  11  12  13  14  15  next     total items: 4675
   
 
Home > Directory > NASDAQ Stock